Cargando…

Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia

OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Marino, Silvia, Bonanno, Lilla, Lo Buono, Viviana, Ciurleo, Rosella, Corallo, Francesco, Morabito, Rosa, Chirico, Gaetano, Marra, Angela, Bramanti, Placido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833431/
https://www.ncbi.nlm.nih.gov/pubmed/31524019
http://dx.doi.org/10.1177/0300060519830830
_version_ 1783466385242849280
author Marino, Silvia
Bonanno, Lilla
Lo Buono, Viviana
Ciurleo, Rosella
Corallo, Francesco
Morabito, Rosa
Chirico, Gaetano
Marra, Angela
Bramanti, Placido
author_facet Marino, Silvia
Bonanno, Lilla
Lo Buono, Viviana
Ciurleo, Rosella
Corallo, Francesco
Morabito, Rosa
Chirico, Gaetano
Marra, Angela
Bramanti, Placido
author_sort Marino, Silvia
collection PubMed
description OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) had neuropsychological and neuroimaging assessment by using automated techniques for cross-sectional and longitudinal atrophy measurements. RESULTS: In the patient with AD, magnetic resonance imaging (MRI) showed decreased bilateral hippocampal and mesial-temporal volume. However, conventional images showed no difference between baseline (T0) and after 1 year (T1). In the patient with bvFTD, MRI showed bilateral frontotemporal lobe atrophy and a moderate increase in atrophy between T0 and T1, particularly in the temporal lobes. A cross-sectional cerebral volume examination showed a considerable reduction in brain volume in the patient with bvFDT and a moderate reduction in the patient with AD. A longitudinal cerebral volume examination showed a lower percentage brain volume change in the patient with bvFTS compared with the patient with AD. CONCLUSIONS: Our results suggest that bvFTD has more neurodegenerative progression. MRI findings should be considered as a reliable marker of disease progression in the brain. Our findings offer potential for monitoring treatment outcomes.
format Online
Article
Text
id pubmed-6833431
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-68334312019-11-13 Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia Marino, Silvia Bonanno, Lilla Lo Buono, Viviana Ciurleo, Rosella Corallo, Francesco Morabito, Rosa Chirico, Gaetano Marra, Angela Bramanti, Placido J Int Med Res Clinical Research Reports OBJECTIVES: Alzheimer’s disease (AD) and behavioral variant frontotemporal dementia (bvFTD) are among the leading causes of early-onset dementia. This study aimed to assess the rate of whole brain atrophy by comparing bvFTD and AD. METHODS: Two patients (one man with AD, and one woman with bvFTD) had neuropsychological and neuroimaging assessment by using automated techniques for cross-sectional and longitudinal atrophy measurements. RESULTS: In the patient with AD, magnetic resonance imaging (MRI) showed decreased bilateral hippocampal and mesial-temporal volume. However, conventional images showed no difference between baseline (T0) and after 1 year (T1). In the patient with bvFTD, MRI showed bilateral frontotemporal lobe atrophy and a moderate increase in atrophy between T0 and T1, particularly in the temporal lobes. A cross-sectional cerebral volume examination showed a considerable reduction in brain volume in the patient with bvFDT and a moderate reduction in the patient with AD. A longitudinal cerebral volume examination showed a lower percentage brain volume change in the patient with bvFTS compared with the patient with AD. CONCLUSIONS: Our results suggest that bvFTD has more neurodegenerative progression. MRI findings should be considered as a reliable marker of disease progression in the brain. Our findings offer potential for monitoring treatment outcomes. SAGE Publications 2019-09-16 2019-10 /pmc/articles/PMC6833431/ /pubmed/31524019 http://dx.doi.org/10.1177/0300060519830830 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Clinical Research Reports
Marino, Silvia
Bonanno, Lilla
Lo Buono, Viviana
Ciurleo, Rosella
Corallo, Francesco
Morabito, Rosa
Chirico, Gaetano
Marra, Angela
Bramanti, Placido
Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title_full Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title_fullStr Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title_full_unstemmed Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title_short Longitudinal analysis of brain atrophy in Alzheimer’s disease and frontotemporal dementia
title_sort longitudinal analysis of brain atrophy in alzheimer’s disease and frontotemporal dementia
topic Clinical Research Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833431/
https://www.ncbi.nlm.nih.gov/pubmed/31524019
http://dx.doi.org/10.1177/0300060519830830
work_keys_str_mv AT marinosilvia longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT bonannolilla longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT lobuonoviviana longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT ciurleorosella longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT corallofrancesco longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT morabitorosa longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT chiricogaetano longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT marraangela longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia
AT bramantiplacido longitudinalanalysisofbrainatrophyinalzheimersdiseaseandfrontotemporaldementia